-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-213-lower-limb-protheses-evidence-summary.pdf
September 01, 2018 - living with limb loss,
a number expected to double by 2050,
mostly due to the rising prevalence of
diabetes … least 65 years
and those in which the percentage of participants with
dysvascular disease (including diabetes … In other words, few studies address the issue
of heterogeneity of treatment effect. … typical lower limb amputees with Medicare
insurance, many of whom have dysvascular conditions
including diabetes … Projection of the year
2050 burden of diabetes in the US adult population: dynamic
modeling of incidence
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/liver-cancer-therapy_research-protocol.pdf
November 28, 2012 - hereditary
hemochromatosis and iron overload syndromes, nonalcoholic fatty liver disease (NAFLD),
obesity, diabetes … In the
continuum of care, use of liver-directed therapies has traditionally preceded treatment with … brachytherapy,
hypofractionated proton beam therapy)
• Transarterial therapies (TAE, TACE, RE,
DEBs … o Were concurrent/concomitant treatments clearly specified and given equally to
treatment groups? … Comparing
across these treatment
categories assumes
patients were eligible
for both treatments.
-
effectivehealthcare.ahrq.gov/sites/default/files/interventions-horizon-scan-high-impact-1306.pdf
June 01, 2013 - new (and new uses of existing) pharmaceuticals, medical
devices, diagnostic tests and procedures, therapeutic … purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs,
devices, procedures, treatments … , screening and diagnostics, therapeutics, surgery, programs, and
care delivery innovations that address … have a major impact on patient management if there
are fewer unplanned ED visits and fewer emergency treatments … Adherence
to long-term therapies.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/atrial-fibrillation-ablation_surveillance.pdf
May 16, 2013 - factors in predicting the
risk of AF recurrence (e.g., age, gender, body mass index, hypertension, diabetes … who received RFA as a second-line therapy
(i.e., patients who did not respond to medical
therapy) … alone (net
difference between the two treatments, +1 to +25
favoring RFA). … catheter
ablation
of
atrial
fibrillation:
the
impact
of
periprocedural
therapeutic … alone
(net
difference
between
the
two
treatments,
+1
to
+25
favoring
-
effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1506.pdf
June 01, 2015 - , screening and diagnostics, therapeutics, surgery, programs, and
care delivery innovations that address … unmet
need for new therapeutic options for patients with IBS. … , alternative therapies are needed. … Bethesda (MD): National
Institute of Diabetes and Digestive and Kidney
Diseases (NIDDK); 2013 Sep … FDA approves two therapies to treat IBS-D.
[internet]. Silver Spring (MD): U.S.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/allergy-seasonal_research-protocol.pdf
March 08, 2012 - smoke, and cold temperatures.21,23 It also provides the rationale for initiating effective
rhinitis therapies … prophylactically before the commencement of pollen season.24,25
Treatment
Treatments for allergic … www.effectivehealthcare.ahrq.gov
Published Online: March 8, 2012
4
caution, if at all, in patients with diabetes … Decisions about which treatments are best during
pregnancy must weigh the potential treatment-related … Antihistamine therapy in allergic rhinitis. Immunol Allergy Clin North
Am 2011 Aug;31(3):509-43.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-surv-report-3-noninvasive-nonpharma_0.xlsx
January 01, 2022 - Physiotherapy (n=45); core stability-based physiotherapy treatment; two sessions of therapy per week … Physiotherapy (n=36); core stability-based physiotherapy treatment; two sessions of therapy per week … during the last 12 months; (4) previous experience in meditation or other mind-body therapies; (5) presence … therapy referral. … physical therapy.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/menopause_disposition-comments.pdf
March 05, 2015 - Menopausal Symptoms: Comparative Effectiveness of Therapies. … that most times, the authors mean “menopausal hormone therapy”
when they say “hormone therapy.” … 5, 2015
20
Commentator
& Affiliation Section Comment Response
Why not include mention of diabetes … risk with hormone therapy use? … Diabetes was not an outcome selected for inclusion.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/disruptive-behavior-disorders-protocol.pdf
January 31, 2023 - Similarly, we
would consider including a study of occupational or other therapies as an adjunct treatment … ,
interpersonal psychotherapy, psychodynamic
therapy, dialectical behavior therapy, equine-
assisted … harms:
Unvalidated outcomes measures
6
- Metabolic effects: weight gain, hyperglycemia and
diabetes … history (e.g., previous psychosocial and pharmacologic treatments, whether or not treatments
are ongoing … " or "multidimensional treatment" or "multisystemic therapy" or "multi-systemic therapy"
or "negative
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-artery-stenosis_appendixes.pdf
April 01, 2005 - Therapeutic safety of perindopril in the
treatment of mild hypertension with
concomitant nephropathy … Enalapril versus
triple-drug therapy in the treatment of
renovascular hypertension. … Renovascular hypertension: results of
medical and surgical therapy. … Stent
angioplasty of severe atherosclerotic ostial
renal artery stenosis in patients with diabetes … heart failure; CKD, chronic kidney disease
(renal insufficiency); CVD, cardiovascular disease; DM, diabetes
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cystic-fibrosis-hgh_appendixes.pdf
January 01, 2009 - )
FEV1 % Predicted
*If not reported as mean and SD, please specify
Concurrent Therapies … Home intravenous
therapy in adult cystic fibrosis patients. … Diabetes Care 2005;28:2141-2144. … Treatment satisfaction,
health-related quality of life and airway clearance therapies in patients … Diabetes mellitus in
patients with cystic fibrosis: The impact of diabetes mellitus on
pulmonary
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/nephropathy-contrast-induced_executive-2016.pdf
January 01, 2016 - Background
The administration of iodinated contrast
media is an essential component of many
diagnostic and therapeutic … object is to help
consumers, health care providers, and
others in making informed choices
among treatment … Effectiveness Reviews,
the program supports systematic
appraisals of existing scientific
evidence regarding treatments … Nephrotoxicity of
iodixanol versus iopamidol in patients with chronic kidney
disease and diabetes mellitus … J Diabetes Complications. 2008 May-
Jun;22(3):171-7. PMID: 18413220.
29.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/treatment-resistant-depression_executive.pdf
September 01, 2011 - as
therapies for patients with TRD: electroconvulsive
therapy (ECT), repetitive transcranial magnetic … Comparisons of these nonpharmacologic
therapies are our main interest. … How do the efficacy, effectiveness, or
harms of treatment with nonpharmacologic
treatments for TRD differ … – Patients with medical comorbidities (e.g.,
seizure history, stroke, diabetes, dementia,
perinatal depression … Direct comparisons of treatment strategies, holding
consistent any coexisting or concomitant therapies
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-260-improved-cancer-outcomes-executive-summary_0.pdf
May 01, 2023 - criteria that define
malnutrition, (2) variability of nutrition interventions (from medical nutrition therapy … current evidence for the effectiveness
of providing nutrition interventions before or during cancer therapy … While studies addressing Key Questions (KQs) 1-3 enrolled individuals from multiple
cancer types, treatments … Assessment of Body
Composition as an Indicator of Early
Peripheral Parenteral Nutrition Therapy in … nutrition on the
nutritional status and blood glucose in
patients with gastric cancer complicated
with diabetes
-
effectivehealthcare.ahrq.gov/sites/default/files/dementia_horizon-scan-high_impact-1306-revised.pdf
July 09, 2013 - new (and new uses of existing) pharmaceuticals, medical devices,
diagnostic tests and procedures, therapeutic … , screening and diagnostics, therapeutics, surgery, programs, and care
delivery innovations that address … and nasal spray bottles.44,46,47 Various insulin products
already approved for use in patients with diabetes … They
thought that the drug’s well-known safety profile and long history of use (in diabetes) would … Intranasal delivery
bypasses the blood-brain barrier to target
therapeutic agents to the central
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/hip-feature-treatment-future_research.pdf
September 23, 2010 - Background
The 2009 systematic literature review “Treatments of Common Hip Fractures” was
conducted … Of the top seven
ranked research questions, only three, treatments for frail elderly patients and the … Collaborators
NCT01051830
(ClinicalTrials.gov)
Care model for hip fractured elderly
persons with diabetes … researchers with broad hip fracture
outcomes and rehabilitation interests were added, including physical therapy … NCT01051830 Care model for hip
fracture patient with diabetes
(Taiwan)
C-3
Key Question/Cross-cutting
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/measuring-blood-pressure_research-protocol.pdf
April 11, 2011 - Measuring BP to diagnose hypertension and monitor therapy is problematic. … treatment-related hypotension. … o Adherence to hypertension treatment. … We will use separate forms for
questions related to treatment (KQs 1–4) and predictors (KQ 5). … We will extract basic demographic data such as age, sex, and race; diabetes, cardiovascular
disease,
-
effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1406.pdf
June 01, 2014 - new (and new uses of existing) pharmaceuticals, medical
devices, diagnostic tests and procedures, therapeutic … purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs,
devices, procedures, treatments … , screening and diagnostics, therapeutics, surgery, programs, and
care delivery innovations that address … No effective treatments are available to
improve long-term nutritional absorption other than intestinal … Bethesda (MD): National Institute of
Diabetes and Digestive and Kidney Diseases
(NIDDK), National
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/disruptive-behavior-disorders-protocol-amendment.pdf
March 22, 2023 - Similarly, we would consider
including a study of occupational or other therapies as an adjunct treatment … ,
interpersonal psychotherapy, psychodynamic
therapy, dialectical behavior therapy, equine-
assisted … Adverse effects/harms:
- Metabolic effects: weight gain, hyperglycemia and
diabetes, hyperlipidemia … history (e.g., previous psychosocial and
pharmacologic treatments, whether or not treatments are ongoing … " or "multidimensional treatment" or "multisystemic therapy" or "multi-systemic therapy"
or "negative
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/antenatal-care.pdf
January 01, 2020 - improve the health and wellbeing
of pregnant patients and their babies through 1) medical screening and treatment … and second trimester ultrasounds (for dating and viability and to
evaluate anatomy, respectively), a diabetes … * Pregnancy complications: maternal mortality, antenatal pregnancy complications (gestational diabetes … All subgroup analyses or other evaluations of heterogeneity of
treatment effect will be extracted. … ACOG Practice Bulletin No. 190: Gestational Diabetes Mellitus.